An EQ-5D-5L value set based on Uruguayan population preferences
暂无分享,去创建一个
Juan Manuel Ramos-Goñi | Federico Augustovski | V. Irazola | F. Augustovski | Luz Gibbons | L. Rey-Ares | O. U. Garay | O. Gianneo | G. Fernández | M. Morales | L. Gibbons | J. Ramos-Goni | Lucila Rey-Ares | Vilma Irazola | Osvaldo Ulises Garay | Oscar Gianneo | Graciela Fernández | Marcelo Morales | J. Ramos-Goñi
[1] N. Devlin,et al. Comprar EQ-5D Value Sets: Inventory, Comparative Review and User Guide | Szende, Agota | 9781402055102 | Springer , 2007 .
[2] Mark Oppe,et al. Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach , 2014, Medical care.
[3] V. Irazola,et al. Argentine valuation of the EQ-5D health states. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] A. Pickard,et al. Validity of EQ-5D-5L in stroke , 2014, Quality of Life Research.
[5] Mark Oppe,et al. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] Michael Herdman,et al. Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states , 2013, The European Journal of Health Economics.
[7] D. Marshall,et al. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement , 2015, Quality of Life Research.
[8] Mark Oppe,et al. EQ-5D value sets : inventory, comparative review, and user guide , 2007 .
[9] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[10] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[11] P. Kind,et al. Social valuation of EQ-5D health states: the Chilean case. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] Frederick R. Forst,et al. On robust estimation of the location parameter , 1980 .
[13] Mark Oppe,et al. Introducing the composite time trade-off: a test of feasibility and face validity , 2013, The European Journal of Health Economics.
[14] Mark Oppe,et al. Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values , 2014, Medical care.
[15] J. Cabasés,et al. Self-Reported Population Health: An International Perspective based on EQ-5D , 2013 .
[16] M. Thavorncharoensap,et al. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients , 2015, Health and Quality of Life Outcomes.
[17] Paul F. M. Krabbe,et al. The development of new research methods for the valuation of EQ-5D-5L , 2013, The European Journal of Health Economics.
[18] G. Hawthorne,et al. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments , 2001, Annals of medicine.
[19] L. Hamilton. How Robust is Robust Regression , 1992 .
[20] L. Lamers. The Transformation of Utilities for Health States Worse Than Death: Consequences for the Estimation of EQ-5D Value Sets , 2007, Medical care.
[21] Mark Oppe,et al. EQ-5D Value Sets , 2007 .
[22] Kevin A. Rader,et al. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty , 2015, Clinical orthopaedics and related research.
[23] T. Kohlmann,et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[24] Dan Greenberg,et al. Trends in the measurement of health utilities in published cost-utility analyses. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[25] P. Kind,et al. Societal Preferences for EQ-5D Health States from a Brazilian Population Survey. , 2013, Value in health regional issues.
[26] Mark Oppe,et al. Lead versus lag time trade-off variants: does it make any difference? , 2013 .
[27] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[28] A. Tsuchiya,et al. Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.